Erlocip 150 mg tab
In stock
Description
Erlocip 150 mg Tablet contains Erlotinib 150 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class.
Uses
Erlocip 150 mg is primarily used for:
Non-small cell lung cancer (NSCLC), particularly cancers with specific EGFR mutations
Advanced pancreatic cancer, usually in combination with gemcitabine.
